Market Cap 20.52M
Revenue (ttm) 2.79M
Net Income (ttm) 9.17M
EPS (ttm) N/A
PE Ratio 2.34
Forward PE N/A
Profit Margin 328.67%
Debt to Equity Ratio 0.00
Volume 2,710,500
Avg Vol 2,519,054
Day's Range N/A - N/A
Shares Out 10.16M
Stochastic %K 21%
Beta 1.47
Analysts Strong Sell
Price Target $5.50

Company Profile

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 759 3680
Fax: 267 759 3681
Address:
12 Penns Trail, Newtown, United States
TopazFrenzy
TopazFrenzy May. 13 at 11:30 AM
$TRAW Back in
0 · Reply
Pinebox32
Pinebox32 May. 13 at 10:36 AM
$TRAW time to add
0 · Reply
InTheMoney_
InTheMoney_ May. 13 at 2:17 AM
$SPY $QQQ $TRAW is down 16% since the cost to borrow rate started spiking finshort.com/TRAW/cost-to-borrow
0 · Reply
Zskylar
Zskylar May. 12 at 9:56 PM
$TRAW been going down since I got in aahh
0 · Reply
Maxelena
Maxelena May. 12 at 8:04 PM
$TRAW 💩 show
0 · Reply
Schube1255
Schube1255 May. 12 at 7:02 PM
$TRAW clinicaltrials.gov - FDA clinical trial starts 11/26 and ends 04/27 , hold will be lifted after trial if effective Traws has NOTHING on the table
0 · Reply
Muntu84
Muntu84 May. 12 at 6:37 PM
0 · Reply
willopond210
willopond210 May. 12 at 6:28 PM
$TRAW by bye Felicia! Now, time for FDA to lift the TXM clinical Hold. $2 by EOD!!!!!! https://www.reuters.com/business/healthcare-pharmaceuticals/fda-commissioner-makary-is-resigning-politico-reports-2026-05-12/
0 · Reply
SexyStockSlayer
SexyStockSlayer May. 12 at 5:12 PM
$TRAW Hantavirus play Traws Pharma recently launched an emergency initiative to develop treatments for Hantavirus, following reports of a rare but fatal outbreak on a cruise ship earlier this month. On May 8, 2026, Traws announced it is accelerating the advancement of clinical candidates specifically targeting Hantavirus infections. Currently, there are no FDA-approved treatments or vaccines for Hantavirus Pulmonary Syndrome (HPS), which has a high mortality rate of 30–50%. Traws is positioning itself to fill this gap for both public health and national security stockpiling. Instead of starting from scratch, Traws is screening its existing library of small-molecule antivirals. Hantavirus is a "negative-strand RNA virus." Traws already has a portfolio of drugs designed to inhibit the replication of similar viruses, such as Influenza, H5N1 (Bird Flu), and SARS-CoV-2.
0 · Reply
willopond210
willopond210 May. 12 at 4:41 PM
$TRAW 23 mins ago
0 · Reply
Latest News on TRAW
Traws Pharma Earnings Call Transcript: Q4 2025

Apr 15, 2026, 4:30 PM EDT - 27 days ago

Traws Pharma Earnings Call Transcript: Q4 2025


Traws Pharma initiated with a Buy at Ladenburg

2026-01-30T12:20:23.000Z - 3 months ago

Traws Pharma initiated with a Buy at Ladenburg


Traws Pharma initiated with a Buy at H.C. Wainwright

2025-12-03T11:10:09.000Z - 5 months ago

Traws Pharma initiated with a Buy at H.C. Wainwright


Traws Pharma reports Q3 EPS (34c) vs ($1.49) last year

2025-11-13T12:05:59.000Z - 6 months ago

Traws Pharma reports Q3 EPS (34c) vs ($1.49) last year


Traws Pharma appoints John Leaman as independent director

2025-10-06T11:37:17.000Z - 7 months ago

Traws Pharma appoints John Leaman as independent director


Traws Pharma Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 9 months ago

Traws Pharma Earnings Call Transcript: Q2 2025


Traws Pharma reports Q2 EPS (11c) vs. ($20.52) last year

2025-08-14T11:16:52.000Z - 9 months ago

Traws Pharma reports Q2 EPS (11c) vs. ($20.52) last year


Traws Pharma announced multiple regulatory submissions

2025-06-30T10:44:40.000Z - 11 months ago

Traws Pharma announced multiple regulatory submissions


Traws Pharma Stock (TRAW) Surges 55% on Positive Cancer Data

2025-06-03T13:48:21.000Z - 1 year ago

Traws Pharma Stock (TRAW) Surges 55% on Positive Cancer Data


Traws Pharma publishes key efficacy data for rigosertib

2025-06-03T11:05:56.000Z - 1 year ago

Traws Pharma publishes key efficacy data for rigosertib


Traws Pharma reports Q1 EPS $2.09) vs ($5.92) last year

2025-05-15T11:14:04.000Z - 1 year ago

Traws Pharma reports Q1 EPS $2.09) vs ($5.92) last year


Traws Pharma Earnings Call Transcript: Q4 2024

Mar 31, 2025, 10:00 AM EDT - 1 year ago

Traws Pharma Earnings Call Transcript: Q4 2024


Traws Pharma reports FY24 EPS ($35.21)

2025-03-31T13:11:18.000Z - 1 year ago

Traws Pharma reports FY24 EPS ($35.21)


Traws Pharma Announces Management Updates

Mar 28, 2025, 4:30 PM EDT - 1 year ago

Traws Pharma Announces Management Updates


Traws Pharma stock soars 200% on encouraging bird flu drug data

Dec 23, 2024, 12:00 PM EST - 1 year ago

Traws Pharma stock soars 200% on encouraging bird flu drug data


Traws Pharma Earnings Call Transcript: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 1 year ago

Traws Pharma Earnings Call Transcript: Q2 2024


Traws Pharma Transcript: M&A Announcement

Apr 2, 2024, 8:30 AM EDT - 2 years ago

Traws Pharma Transcript: M&A Announcement


Traws Pharma Announces New Employee Inducement Grants

Apr 2, 2024, 7:15 AM EDT - 2 years ago

Traws Pharma Announces New Employee Inducement Grants


Traws Pharma Earnings Call Transcript: Q3 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

Traws Pharma Earnings Call Transcript: Q3 2023


Onconova Expands Leadership Team with Two Key Appointments

Oct 24, 2023, 8:00 AM EDT - 2 years ago

Onconova Expands Leadership Team with Two Key Appointments


Traws Pharma Earnings Call Transcript: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 2 years ago

Traws Pharma Earnings Call Transcript: Q2 2023


Traws Pharma Earnings Call Transcript: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

Traws Pharma Earnings Call Transcript: Q1 2023


TopazFrenzy
TopazFrenzy May. 13 at 11:30 AM
$TRAW Back in
0 · Reply
Pinebox32
Pinebox32 May. 13 at 10:36 AM
$TRAW time to add
0 · Reply
InTheMoney_
InTheMoney_ May. 13 at 2:17 AM
$SPY $QQQ $TRAW is down 16% since the cost to borrow rate started spiking finshort.com/TRAW/cost-to-borrow
0 · Reply
Zskylar
Zskylar May. 12 at 9:56 PM
$TRAW been going down since I got in aahh
0 · Reply
Maxelena
Maxelena May. 12 at 8:04 PM
$TRAW 💩 show
0 · Reply
Schube1255
Schube1255 May. 12 at 7:02 PM
$TRAW clinicaltrials.gov - FDA clinical trial starts 11/26 and ends 04/27 , hold will be lifted after trial if effective Traws has NOTHING on the table
0 · Reply
Muntu84
Muntu84 May. 12 at 6:37 PM
0 · Reply
willopond210
willopond210 May. 12 at 6:28 PM
$TRAW by bye Felicia! Now, time for FDA to lift the TXM clinical Hold. $2 by EOD!!!!!! https://www.reuters.com/business/healthcare-pharmaceuticals/fda-commissioner-makary-is-resigning-politico-reports-2026-05-12/
0 · Reply
SexyStockSlayer
SexyStockSlayer May. 12 at 5:12 PM
$TRAW Hantavirus play Traws Pharma recently launched an emergency initiative to develop treatments for Hantavirus, following reports of a rare but fatal outbreak on a cruise ship earlier this month. On May 8, 2026, Traws announced it is accelerating the advancement of clinical candidates specifically targeting Hantavirus infections. Currently, there are no FDA-approved treatments or vaccines for Hantavirus Pulmonary Syndrome (HPS), which has a high mortality rate of 30–50%. Traws is positioning itself to fill this gap for both public health and national security stockpiling. Instead of starting from scratch, Traws is screening its existing library of small-molecule antivirals. Hantavirus is a "negative-strand RNA virus." Traws already has a portfolio of drugs designed to inhibit the replication of similar viruses, such as Influenza, H5N1 (Bird Flu), and SARS-CoV-2.
0 · Reply
willopond210
willopond210 May. 12 at 4:41 PM
$TRAW 23 mins ago
0 · Reply
willopond210
willopond210 May. 12 at 4:32 PM
$TRAW How fast will TRAW push their drug? Hopefully, faster than the red dots on this map. https://hantavirusmap.com/?tier=official%2Cemerging%2Cchatter
0 · Reply
willopond210
willopond210 May. 12 at 3:47 PM
$TRAW back over $2 today!
1 · Reply
Jbjb90
Jbjb90 May. 12 at 3:00 PM
$TRAW ratutrelvir update, clinical hold lift on TXM, or an clinical progress on a hanta virus candidate and we fly. 1-2 load zone, 2-3 still cheap, 3-5 where we belong, great news 5+, just my opinion
1 · Reply
Dickman777
Dickman777 May. 12 at 2:58 PM
$TRAW adding here too, as more cases of this virus are appearing daily!! Kind of a no brainer!
0 · Reply
willopond210
willopond210 May. 12 at 2:41 PM
$TRAW hold my beer! ready for the whiplash?
1 · Reply
Dwarn2021
Dwarn2021 May. 12 at 2:28 PM
$TRAW This guy, not trading, investing: Sirenia Capital Management was launched by veteran portfolio manager Alex Silverstein, who spun out his healthcare trading team from Point72 Asset Management, where he had been one of its most successful portfolio managers for 13 years. Point72 provided its largest-ever initial backing , committing hundreds of millions of dollars — which could translate into multiple billions in buying power with leverage. This surpassed the $200 million Point72 provided to Gabe Plotkin when he launched Melvin Capital Management in 2015. Sirenia invests primarily in public and private equity positions in healthcare and biotechnology companies, and may use derivatives and index-related instruments for hedging and risk management purposes. Sirenia essentially a high-profile, healthcare-specialist hedge fund — newly launched but immediately well-capitalized, making its involvement in the TRAWS Pharma PIPE a natural fit given TRAW's antiviral drug pipeline.
0 · Reply
urgetosurge
urgetosurge May. 12 at 2:25 PM
$TRAW it's all in the filing. Share bags for everybody. Always check filings for dilution traps.
0 · Reply
investORnot
investORnot May. 12 at 2:19 PM
$TRAW now we short HEAVVYYYY Lfg
0 · Reply
investORnot
investORnot May. 12 at 2:14 PM
$TRAW gotta know when to cut losses. Trash gonna keep bleeding.
0 · Reply
007Agent
007Agent May. 12 at 1:58 PM
$TRAW what is happening in up normal, shorts want to recover as soon as possible
0 · Reply
007Agent
007Agent May. 12 at 1:55 PM
$TRAW STOCK WILL HIT $4.X TODAY
1 · Reply
Dwarn2021
Dwarn2021 May. 12 at 1:52 PM
$TRAW adding here
0 · Reply